Insider Sale by Aslan Fred (Chief Executive Officer)
Trade Summary
2 days ago, Aslan Fred, serving as Chief Executive Officer at Artiva Biotherapeutics, Inc. (ARTV), sold 23,429 shares at $10.92 per share, for a total transaction value of $255,746.28. Following this transaction, Aslan Fred now holds 1,449,765 shares of ARTV.
This sale represents a 1.59% decrease in Aslan Fred's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Tuesday, September 8, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 9, 2026 at 4:02 PM ET, 1 day after the trade was made.
Artiva Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$10.92
Quantity
23,429
Total Value
$255,746.28
Shares Owned
1,449,765
Trade Date
2 days ago
SEC Filing Date
at 4:02 PM ET
Filed 1 day after trade
Discussion